Potential mechanism of ginger (Zingiber Officinale Roscoe) in alleviating osteoporosis
Open Access
- 24 September 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 16, 1607278
Abstract
Osteoporosis (OP), a prevalent metabolic bone disease, significantly compromises patients’ quality of life and overall health. In recent years, with the advancement of natural product research, ginger (Zingiber Officinale Roscoe) has garnered attention for its potential anti-osteoporotic effects. This review summarizes the clinical and basic research progress of ginger in alleviating OP, focusing on the mechanisms by which ginger exerts its effects through multiple signaling pathways, including NF-κB, Wnt/β-catenin, MAPK, GSK3β/Nrf2, and RANK/RANKL/OPG. By comprehensively analyzing existing literature, this study explores the research significance and limitations of ginger and its active metabolites in the treatment of OP, and proposes future research directions, aiming to provide theoretical support and reference for the development of novel anti-osteoporotic drugs.Keywords
This publication has 60 references indexed in Scilit:
- Screening for Osteoporosis to Prevent FracturesJAMA, 2025
- Mechanistic advances in osteoporosis and anti‐osteoporosis therapiesMedcomm, 2023
- Revisiting the therapeutic potential of gingerols against different pharmacological activitiesNaunyn-Schmiedeberg's Archives of Pharmacology, 2022
- Curcumin suppress inflammatory response in traumatic brain injury via p38/MAPK signaling pathwayPhytotherapy Research, 2022
- [8]‐Gingerol exerts anti‐myocardial ischemic effects in rats via modulation of the MAPK signaling pathway and L‐type Ca2+ channelsPharmacology Research & Perspectives, 2021
- Curcumin regulates EZH2/Wnt/β‐Catenin pathway in the mandible and femur of ovariectomized osteoporosis ratsThe Kaohsiung Journal of Medical Sciences, 2021
- Ginger (Zingiber officinaleRosc.) and its bioactive components are potential resources for health beneficial agentsPhytotherapy Research, 2020
- 6‐Shogaol, an active ingredient of ginger, inhibits osteoclastogenesis and alveolar bone resorption in ligature‐induced periodontitis in miceJournal of Periodontology, 2019
- Osteogenic potential of zingerone, a phenolic compound in mouse mesenchymal stem cellsBioFactors, 2019
- The ginger component 6-shogaol prevents TNF-α-induced barrier loss via inhibition of PI3K/Akt and NF-κB signalingMolecular Nutrition & Food Research, 2016